Literature DB >> 14965584

Nuclear medicine and breast cancer: a review of current strategies and novel therapies.

P Berghammer1, R Obwegeser, H Sinzinger.   

Abstract

While breast cancer is still increasing in frequency, new diagnostic procedures are now available to challenge existing procedures and to make diagnosis of breast cancer more accurate and reliable. Mammography remains the standard investigation to reveal disease in an asymptomatic population: it can also be used to diagnose breast cancer in symptomatic patients (e.g. those with palpable breast lumps) and for guiding fine needle aspiration (FNA). Because the majority of breast lumps are benign, the challenge is to distinguish benign from malignant lesions without the use of invasive methods and this has attracted nuclear medicine physicians and medical oncologists to investigate the role of scintigraphic procedures to identify which patients require FNA. This review attempts to shed light on the various scintigraphic methods available which are of potential practical use in the assessment of malignant breast disease as well as looking at the possible role of nuclear medicine in the treatment of advanced disease.

Entities:  

Year:  2001        PMID: 14965584     DOI: 10.1054/brst.2000.0214

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  1 in total

1.  The relationship between expression of the sodium/iodide symporter gene and the status of hormonal receptors in human breast cancer tissue.

Authors:  Hyun Jung Oh; June-Key Chung; Joo Hyun Kang; Won Jun Kang; Dong Young Noh; In Ae Park; Jae Min Jeong; Dong Soo Lee; Myung Chul Lee
Journal:  Cancer Res Treat       Date:  2005-08-31       Impact factor: 4.679

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.